The addition of bevacizumab in the adjuvant chemotherapy of cancer patients increases the incidence of major cardiovascular events: a prospective study
The addition of bevacizumab in the adjuvant chemotherapy of cancer patients increases the incidence of major cardiovascular events: a prospective study
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2012
Authors:
Michelongona, A Toutouzas, K Synetos, A Tsiamis, E Zagouri, F Bamias, A Dimopoulos, MA Kyvelou, S Tousoulis, D Stefanadis, C
